BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 23090531)

  • 1. Endometrioid endometrial carcinoma with atrophic endometrium and poor prognosis.
    Geels YP; Pijnenborg JM; van den Berg-van Erp SH; Bulten J; Visscher DW; Dowdy SC; Massuger LF
    Obstet Gynecol; 2012 Nov; 120(5):1124-31. PubMed ID: 23090531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium.
    Geels YP; van der Putten LJ; van Tilborg AA; Lurkin I; Zwarthoff EC; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Visscher DW; Dowdy SC; Massuger LF
    Gynecol Oncol; 2015 May; 137(2):245-51. PubMed ID: 25773202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic Association and Prognostic Value of Microcystic, Elongated, and Fragmented (MELF) Pattern in Endometrial Endometrioid Carcinoma.
    Kihara A; Yoshida H; Watanabe R; Takahashi K; Kato T; Ino Y; Kitagawa M; Hiraoka N
    Am J Surg Pathol; 2017 Jul; 41(7):896-905. PubMed ID: 28418994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological findings in early-stage endometrial cancer.
    Zehavi S; Schneider D; Bukovsky I; Halperin R
    Eur J Gynaecol Oncol; 2003; 24(1):18-20. PubMed ID: 12691310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma.
    Geels YP; Pijnenborg JM; Gordon BB; Fogel M; Altevogt P; Masadah R; Bulten J; van Kempen LC; Massuger LF
    Pathol Oncol Res; 2016 Oct; 22(4):863-8. PubMed ID: 26891628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases.
    Zhang C; Sung CJ; Quddus MR; Simon RA; Jazaerly T; Lawrence WD
    Hum Pathol; 2017 Jan; 59():120-124. PubMed ID: 27746268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relationship between the pathologic features of the uninvolved endometrium and prognosis in postmenopausal endometrial carcinoma].
    Wang L; Zhou X; Du X
    Zhonghua Fu Chan Ke Za Zhi; 1997 Oct; 32(10):605-8. PubMed ID: 9642377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.
    Pasanen A; Tuomi T; Isola J; Staff S; Bützow R; Loukovaara M
    Int J Gynecol Cancer; 2016 Oct; 26(8):1465-71. PubMed ID: 27648714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF; Pizer ES; Ronnett BM; Kurman RJ
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic analysis: relationship between endometrial carcinoma and uninvolved endometrium.
    Dane C; Tatar Z; Dane B; Cetin A
    Eur J Gynaecol Oncol; 2009; 30(1):71-4. PubMed ID: 19317261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

  • 13. Pure compared with mixed serous endometrial carcinoma: two different entities?
    Roelofsen T; van Ham MA; Wiersma van Tilburg JM; Zomer SF; Bol M; Massuger LF; Bulten J
    Obstet Gynecol; 2012 Dec; 120(6):1371-81. PubMed ID: 23168762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
    Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A
    Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prior Tubal Ligation Might Influence Metastatic Spread of Nonendometrioid Endometrial Carcinoma.
    Li M; Li M; Zhao L; Wang Z; Wang Y; Shen D; Wang J; Wei L
    Int J Gynecol Cancer; 2016 Jul; 26(6):1092-7. PubMed ID: 27104940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic parameters in FIGO stage I endometrial carcinoma of endometrioid type].
    Stanojević Z; Dordević B
    Vojnosanit Pregl; 2006 Dec; 63(12):1006-10. PubMed ID: 17252704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profiles of benign and (pre)malignant endometrial lesions.
    van der Putten LJM; van Hoof R; Tops BBJ; Snijders MPLM; van den Berg-van Erp SH; van der Wurff AAM; Bulten J; Pijnenborg JMA; Massuger LFAG
    Carcinogenesis; 2017 Mar; 38(3):329-335. PubMed ID: 28203752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment.
    Barlin JN; Soslow RA; Lutz M; Zhou QC; St Clair CM; Leitao MM; Iasonos A; Hensley ML; Barakat RR; Matias-Guiu X; Abu-Rustum NR
    Int J Gynecol Cancer; 2013 Nov; 23(9):1620-8. PubMed ID: 24126219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2 expression and prognosis of patients with endometrial carcinoma.
    Sakuragi N; Ohkouchi T; Hareyama H; Ikeda K; Watari H; Fujimoto T; Kuwabara M; Yamamoto R; Sagawa T; Fujino T; Fujimoto S
    Int J Cancer; 1998 Apr; 79(2):153-8. PubMed ID: 9583730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.